Related Experiment Videos
[Uveitis in leprosy patients]
1National Leprosarium Tama-Zenshoen, Tokyo.
Nihon Rai Gakkai Zasshi
|November 1, 1995
Summary
Incomplete leprosy treatment may lead to late-stage uveitis (UV), even years after bacterial negativity. Lower chemotherapy scores and higher antibodies indicate higher risk for this persistent ocular inflammation.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Immunology
Context:
- Leprosy, a chronic infectious disease, can cause ocular complications like uveitis (UV) even after dermatological cure.
- Late-phase uveitis in leprosy patients requires understanding risk factors for better management.
- Patients studied were dermatologically cured, skin smear negative for over 10 years, but had ongoing uveitis.
Purpose:
- To investigate the risk factors associated with late-phase uveitis in leprosy patients who are dermatologically cured.
- To compare antibody levels and chemotherapy history between leprosy patients with and without uveitis.
Summary:
- Anti-PGL-I and anti-LAM-B antibodies were elevated in leprosy patients with uveitis (UV+) compared to controls (UV-).
- Patients with uveitis had a significantly lower chemotherapy "SCORE", indicating potentially insufficient treatment.
- Iris pearls, a clinical sign of ocular inflammation, were observed in 42% of UV+ patients but none in controls.
Impact:
- Findings suggest that insufficient chemotherapy and incomplete Mycobacterium leprae elimination are risk factors for developing uveitis in quiescent leprosy.
- This highlights the importance of adequate treatment duration and monitoring for ocular complications in leprosy survivors.
- Understanding these risk factors can guide preventative strategies and improve long-term patient outcomes.